PL

Philip T. Lavin

Chief Methodologist at NRx Pharmaceuticals

Dr. Lavin is a highly respected biostatistician with more than 30 years experience supporting the design and analysis of clinical trials. Previously, he was a member of the biostatistics facult at the Harvard School of Public Health and a member of the Department of Surgery at Harvard Medical School where he was affiliated for over 25 years. He co-founded Boston Biostatistics in 1983, a company known as Aptiv Solutions. During his career, Dr. Lavin has served as lead biostatistician for 50 FDA approvals, including 38 PMAs, more to date than any other biostatistician. He has also server as a Special Government Employee for 30 years where he has advised the FDA on complex statistical and policy issues.

Timeline

  • Chief Methodologist

    Current role

View in org chart